» Articles » PMID: 17995942

Visceral Adipose Tissue Area is an Independent Risk Factor for Hepatic Steatosis

Overview
Specialty Gastroenterology
Date 2007 Nov 13
PMID 17995942
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: Recent data indicate that hepatic steatosis is associated with insulin resistance, dyslipidemia and obesity (especially central body fat distribution). There have been few studies on the correlation between biopsy-proven hepatic steatosis and the above factors in a disease-free population. The aim of the present study was to evaluate the relation between hepatic steatosis assessed by biopsy and clinical characteristics including regional fat distribution measured by computed tomography (CT) in living liver donors.

Methods: Laboratory data, liver/spleen Hounsfield ratio (L/S ratio), regional fat distribution by CT and liver status by biopsy were evaluated retrospectively in a total of 177 living liver donors without a history of alcohol intake.

Results: The unpaired t-test showed that age, triglycerides (TG), high density lipoprotein, total cholesterol, alanine aminotransferase, body mass index, L/S ratio, visceral adipose tissue area (VAT) and subcutaneous adipose tissue area (SAT) were associated with hepatic steatosis. In the multiple logistic regression analysis, VAT (odds ratio 1.031, 95% CI 1.013-1.048, P < 0.01) and TG (odds ratio 1.012, 95% CI 1.004-1.020, P < 0.01) were independent risk factors of hepatic steatosis. Subgroup analysis also showed that VAT was an independent risk factor in men (odds ratio 1.022, 95% CI 1.003-1.041, P < 0.05) and women (odds ratio 1.086, 95% CI 1.010-1.168, P < 0.05).

Conclusion: Our results suggest that visceral abdominal adiposity is correlated with hepatic steatosis in healthy living liver donors.

Citing Articles

Associations between Chinese Visceral Adiposity Index and the Risk of Metabolic Dysfunction-associated Steatotic Liver Disease and Liver Fibrosis: A Large Cross-sectional Study.

Liu H, Deng M, Luo G, Chen J Iran J Med Sci. 2025; 50(1):11-21.

PMID: 39957808 PMC: 11829064. DOI: 10.30476/ijms.2024.100818.3335.


BMI gain and dietary characteristics are risk factors of MASLD in non-obese individuals.

Taniguchi H, Ueda M, Kobayashi Y, Shima T Sci Rep. 2025; 15(1):2606.

PMID: 39838114 PMC: 11751101. DOI: 10.1038/s41598-025-86424-x.


Visceral fat area and subcutaneous fat area as measures of body composition in soft tissue sarcoma.

Garibay E, Cruz S, Judge S, Monjazeb A, Thorpe S, Murphy W J Surg Oncol. 2024; 130(3):543-551.

PMID: 39402905 PMC: 11753180. DOI: 10.1002/jso.27751.


Central Obesity is an Independent Determinant of Advanced Fibrosis in Lean Patients With Nonalcoholic Fatty Liver Disease.

De A, Bhagat N, Mehta M, Singh P, Rathi S, Verma N J Clin Exp Hepatol. 2024; 15(1):102400.

PMID: 39282592 PMC: 11399567. DOI: 10.1016/j.jceh.2024.102400.


The Link between Abdominal Obesity Indices and the Progression of Liver Fibrosis: Insights from a Population-Based Study.

Julian M, Arteaga I, Toran-Monserrat P, Pera G, Perez-Montes de Oca A, Ruiz-Rojano I Nutrients. 2024; 16(11).

PMID: 38892518 PMC: 11174397. DOI: 10.3390/nu16111586.